Epigenetic regulator explains why some lung cancer patients become resistant to common therapeutics
Doctors typically treat people with non-small cell lung cancer, a prevalent and typically incurable type of cancer that makes up 80%-85% of lung cancers, with tyrosine kinase inhibitors, specifically epidermal growth factor ...
Apr 12, 2022
0
16
